According to PL Capital, Ajanta Pharma's strong franchise will aid in garnering a higher market share for semaglutide ...

Ajanta Pharma shares gained 3% despite a weak market as analysts turned bullish on its Biocon partnership, semaglutide ...

Ajanta Pharma shares were trading in green during Tuesday's intraday trade. Ajanta Pharma shares had touched a 52-week high ...

Ajanta Pharma secures exclusive rights to market Biocon's semaglutide in 26 countries, targeting growth in diabetes and ...

Indian drugmaker Biocon has announced the signing of an out-licensing agreement with Ajanta Pharma to market its vertically ...

INSV Kaundinya, the Indian Navy’s stitched sailing vessel recreated from depictions of ancient Indian ships in Ajanta Cave ...

Given Ajanta’s improving business mix and robust cash generation, its share valuation appears reasonable for a company ...

Yogesh Agrawal, MD of Ajanta Pharma outlined Ajanta Pharma’s strategy to capitalise on the opportunity through its ...

Ajanta Pharma plans to sell generic semaglutide in 26 countries, in a partnership with Biocon, capitalizing on patent ...

Semaglutide is indicated to improve glycaemic control in adults. Ajanta Pharma said it plans to commercialise the product ...

During her 15-day journey, the ship will retrace ancient maritime routes that once connected India with West Asia and the ...

To date, yesteryear bollywood superstar Jeetendra has appeared in only one television commercial to endorse a product. That was in the 1990s, for a popular over-the-counter (OTC) energiser capsule for ...